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Abstract
Background: The purpose of this study is to explore how a patient’s height and weight can be used to predict
the effective dose to a reference phantom with similar height and weight from a chest abdomen pelvis computed
tomography scan when machine-based parameters are unknown. Since machine-based scanning parameters can
be misplaced or lost, a predictive model will enable the medical professional to quantify a patient’s cumulative
radiation dose.
Methods: One hundred mathematical phantoms of varying heights and weights were defined within an x-ray
Monte Carlo based software code in order to calculate organ absorbed doses and effective doses from a chest
abdomen pelvis scan. Regression analysis was used to develop an effective dose predictive model. The regression
model was experimentally verified using anthropomorphic phantoms and validated against a real patient
population.
Results: Estimates of the effective doses as calculated by the predictive model were within 10% of the estimates
of the effective doses using experimentally measured absorbed doses within the anthropomorphic phantoms.
Comparisons of the patient population effective doses show that the predictive model is within 33% of current
methods of estimating effective dose using machine-based parameters.
Conclusions: A patient’s height and weight can be used to estimate the effective dose from a chest abdomen
pelvis computed tomography scan. The presented predictive model can be used interchangeably with current
effective dose estimating techniques that rely on computed tomography machine-based techniques.
Background
This research was driven by the need to estimate the
radiation dose from computed tomography scans given
to soldiers and civilians injured in austere environments.
Nearly 50% of all injuries to United States Army soldiers
in Operation Iraqi Freedom and Operation Enduring
Freedom occurred in the head/neck, abdomen, and
thorax region of the body [1,2]. Injuries in these regions
are most commonly assessed using diagnostic x-ray
scanning modalities such as computed tomography
(CT). Current CT machines are able to scan an entire
body in as little as 30 seconds making them particularly
advantageous for diagnosing the extent of injuries sus-
tained in traumatic events [3]. As a result, CT scanning
is an integral part of the medical treatment schema
from patient initial diagnosis through rehabilitation. In
fact, because of this, CT scanning usage has steadily
increased since its inception in 1972 [4]. While CT
scanners have traditionally been used in fixed large hos-
pital facilities technological advancements have made
deployable CT machines a reality on battlefield environ-
ments [5].
While CT imaging as many advantages over other diag-
nostic modalities for diagnosing trauma injuries, it does
have some drawbacks. CT procedures give patients more
radiation dose than traditional x-ray imaging modalities.
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e x p o s e dt om o r ed o s ew h i c hm a yr e s u l ti nu n i n t e n d e d
health effects. As such, trade-offs exist between risk and
benefit in the use of CT. In order to manage the risks
associated with CT effectively, healthcare providers need
to be able to estimate and track the dose these patients
receive from their CT scan(s). Additionally, CT generates
an order of magnitude more information than traditional
medical imaging modalities.
The Joint Patient Tracking Application was developed
to allow users to get real-time information on the status
of their injured troops [6]. However, the trauma record
does not show how many radiographic procedures were
performed in the trauma diagnosis. Furthermore,
advances in diagnostic imaging have not made the man-
agement of patient imaging records easier. This is illu-
strated by the fact that for a brief time period, one
combat hospital switched from film radiography to digital
radiography and then back to film radiography because of
increased throughput during trauma situations and the
inability of outside facilities to read the compact disks
with the films saved on them [7].
The probability of repeat diagnostic scanning proce-
dures increases when failure to transfer relevant under-
standable radiographic information along with the
patient occurs. Additionally, as the level of integrated
hospital care increases, the radiographic technology also
increases resulting in multiple diagnostic procedures on
the same area with different diagnostic modalities.
Increasing numbers of radiographic procedures are not
unique to military medicine. Victims of trauma receive
multiple diagnostic scans and thus are at an increased
risk of detrimental health risks from cumulative radiation
dose [3,8,9].
Quantification of the risk derived from the repeated
use of CT scans is needed in order to assess the conse-
quences of the increased dose to these soldiers. A com-
mon metric for estimating the dose from CT scans,
effective dose, describes the relationship between the
probability of stochastic effects from radiation and
equivalent dose for a mathematical reference phan-
tom [10]. Estimating the effe c t i v ed o s ei su s u a l l yp e r -
formed using machine-based parameters and derived
conversion coefficients [4,11].
However, if the CT machine-based parameters for the
s c a na r eu n k n o w nb e c a u s et h er e q u i s i t ei n f o r m a t i o ni s
lost as a patient is transferred from one hospital to
another, the only other means of estimating the effective
dose from a CT scan is through the use of broad esti-
mates based on published nominal values [12]. We pro-
pose an alternate method that estimates the chest
abdomen pelvis scan effective dose to a mathematical
phantom based upon the patient’s height and weight at
the time of the scan.
Methods
The approach we took to develop the alternate method for
estimating effective dose involved three steps. The first
step required the development of a mathematical model
based upon a fictitious population of phantoms represent-
ing a range of body parameters common for U.S. Army
soldiers. The second step verified the model by compari-
son of absorbed doses to organs using anthropomorphic
phantoms. Finally, the third step validated the model with
a real patient dataset. The development of estimating the
effective dose model differs from the current method of
estimation which uses machine-based parameters.
The most common method of estimating the effective
dose when machine-based parameters from a CT scan
are available involves multiplying the dose-length-pro-
duct (DLP), a product of the volume computed tomo-
graphy dose index (CTDIvol) and the scanning length, by
a conversion coefficient. The DLP is available by refer-
encing the dose report generated by most commercial
scanners at the end of the CT scanning procedure. Con-
version coefficients have been derived using Monte
Carlo simulations and experimental measurements.
Commercial CT scanners provide an estimate of the
DLP in the dose report generated at the end of a scan-
ning procedure. The DLP is derived from the CTDIvol
which is measured using a 32-cm diameter acrylic cylin-
der and a 100-mm long pencil shaped ionization cham-
ber [13]. The chamber provides the dosimetry
measurements at the center of the cylinder (c) and on
the periphery (p) of the cylinder from which the
weighted CTDI (CTDIw) is calculated using
CTDIw =
2
3
CTDIp +
1
3
CTDIc. (1)
CTDIvol is calculated by considering both the CTDIw
and the pitch of the machine given by
CTDIvol =
CTDIw
pitch
, (2)
where pitch is the table increment travelled per com-
plete rotation of the x-ray tube. DLP is the product of
the CTDIvol and the scan length.
DLP = CTDIvol × scan length (3)
Effective dose, the primary outcome measure of our
study, can be calculated from the CT machine-based para-
meters and is the product of the DLP (mGy cm) and spe-
cific conversion coefficients (CC) (mSv mGy
-1 cm
-1), using
E=D L P× CC (4)
Conversion coefficients are available in several publi-
cations including the American Association of Physicists
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Council on Radiation Protection and Measurements
(NCRP) Report 160 [4]. The conversion coefficient used
in our study for a chest abdomen pelvis (CAP) scan is
0.015 mSv mGy
-1 cm
-1[14].
The radiation dose from axial scanning is converted to
radiation dose from helical scanning by dividing the
axial scanning dose by the CT pitch.
We used a commercially available software program,
(PCXMC 2.0.1 (Personal Computing X-ray Monte Carlo),
STUK, Finland) [15], for calculating patient average
absorbed organ doses in medical x-ray examinations. The
software uses mathematical hermaphrodite phantoms.
As the software is primarily designed for projection
radiography, four projections (anterior posterior (AP), pos-
terior anterior (PA), right lateral (RLAT), and left lateral
(LLAT)) were used to simulate a 360 degree exposure
from a CT machine [16]. Each projection had the same
slice thickness as a CT axial slice. Calibration factors were
developed for effective dose comparison with a commonly
used CT software program (ImPACT CT Patient Dosime-
try Calculator, version 0.99x; ImPACT, London, England).
Mathematical phantoms of varying sizes were developed
to represent the range of sizes of U.S. Army soldiers. Typi-
cal-sized U.S. Army soldiers have a body mass index (BMI,
kg/m
2) of 20 to 30 [17,18]. Development of the phantom
population used BMI, ranging from 18 (underweight) to
36 (obese), as a means of determining the height and
weight of a theoretical U.S. Army population. Correspond-
ing heights and weights were calculated from the BMI
values. One hundred hermaphrodite mathematical phan-
toms with height and weight ranging from 5 feet 1 inch up
to 6 feet 7 inches and 95 pounds up to 317 pounds were
configured for use within the software. The methodology
for determining the number of phantoms of varying height
and weight was based on common guidelines that suggest
the use of ten observations for each predictor [19,20].
In our study, all dose calculations per slice were simu-
lated with 1 × 10
6 photons. Anode angle was set at 7
degrees with a beam quality half-value layer of 7.4 mm
aluminum [21]. X-ray tube voltage was set at 120 kV for
all calculations and software-required entrance air kerma
values were obtained from measurements of the four pro-
jections at the center point of a typical chest abdomen pel-
vis scan using an anthropomorphic phantom. Averaged
absorbed doses to organs were generated and recorded.
Multivariate regression analysis was performed using the
R Project for Statistical Computing statistical program [22]
in order to determine a best-fit model using height and
weight as predictors of the effective dose. Full regression
models were generated that identified effective dose as the
dependent variable and the independent variables as
height (cm), height
2 (cm
2), weight (kg), and weight
2 (kg
2).
Bayesian information criterion techniques were used for
variable selection. Statistical significance was defined as
p<0 . 0 5 .
Experimental verification measurements were performed
using two adult anthropomorphic phantoms (CIRS, Inc.,
Norfolk, Virginia). The female adult anthropomorphic
phantom (height 160 cm and weight 55 kg) and male
adult anthropomorphic phantom (height 173 cm and
weight 73 kg) were manufactured with dosimetry verifica-
tion plugs enlarged to accommodate optically stimulated
luminescent dosimeters utilizing an Al2O3 detector (Land-
auer Nanodot, Landauer, Inc., Glenwood, IL). All com-
puted tomography scans were performed using a GE
LightSpeed 16 (General Electric Healthcare, Waukesha,
WI) (Figure 1). Manufacturer recommended calibration
procedures were followed prior to irradiation [23]. For the
purposes of this study, an 80 kVp calibration set was used
and final dosimeter readings were adjusted to account for
CT scanning (at 120 kVp) by multiplying each final read-
ing by 1.15 based upon an experimentally determined
energy response curve corresponding to the manufacturer
calibration and usage instructions.
Figure 1 Representative Chest Abdomen Pelvis Scanning
Range. Representative scanning range (vertical dashed line) of a
chest abdomen pelvis (CAP) scan.
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mental technique factors: 120 kVp, automatic mA (220 -
380 mA), slice thickness of 10-mm, and a helical scan-
ning pitch 1.375.
The model for estimating effective dose presented in this
paper was compared to the method of estimating effective
dose using DLP and conversion coefficients because this
latter method is the current accepted method [11,24]. An
institutional review board approved retrospective study
(Memorial Sloan-Kettering Cancer Center WA 0313-10
dated 23 June 2010) (n = 28) was conducted to compare
the developed height weight predictive effective dose
model with the current effective dose estimation method
of multiplying the DLP by a published conversion coeffi-
cient. A Bland-Altman plot was used to visually inspect
the variation between the two methods of estimating the
effective dose. Bland-Altman plots (also known as an aver-
age versus difference plot) show the average of the meth-
ods on the x-axis and the difference between the methods
on the y-axis [25]. This type of plot is effective in visually
displaying the potential for systematic differences and
method agreements.
Results
In the univariate analysis, patient height (H) (cm) and
weight (W) (kg) demonstrated a significant association
with effective dose (E) (mSv) and were entered into the
multivariable linear regression analysis (equation 5). The
variation (R
2 = 0.96) in the effective dose is primarily
explained by a patient’s height and weight. In the multi-
variable linear regression analysis, increasing patient height
had a positive effect on the effective dose whereas increas-
ing patient weight had a negative effect on the effective
dose. A 1-cm increase in a patient’s height is associated
with a 0.3% increase in the effective dose. Similarly, a 1-kg
increase in a patient’sw e i g h ti sa s s o c i a t e dw i t ha0 . 5 %
decrease in the effective dose given by
E( m S v )=1 8+0 . 0 6 7H ( c m )− 0.11 W (kg). (5)
Since effective dose is not a measurable quantity in and
of itself, verification of the model (equation 5) was con-
ducted by comparing experimentally obtained organ doses
for eleven different organs which represent important
components of effective dose to the organs doses esti-
mated using the Monte Carlo software code. All of the
organs listed in the tables (tables 1 and 2) are included
within the primary scanning field of view except the brain
and eyes.
The percent difference between the effective doses
determined using either the mathematical phantom or
experimental measurement is9 %f o rt h ef e m a l ea n t h r o -
pomorphic phantom and 5% for male anthropomorphic
phantom.
The absolute percent difference of the average effective
dose for the IRB-approved population (n = 28) for the two
means of calculating the effective doses was 33%. The
population average effective dose calculated using the pre-
dictive model was 21 ± 2 mSv, while the population aver-
age effective dose calculated using the DLP CC method
was 15 ± 5 mSv (Figure 2). Three of the four effective dose
outliers shown on the predictive model plot are due to the
patient BMI being greater than the range of BMIs (18 - 36
kg m
-2) used to develop the predictive model. The fourth
effective dose outlier shown on the predictive model plot
is due to the patient BMI (35 kg m
-2) being at the upper
range of the BMIs used to develop the predictive model.
The two means of calculating the effective doses are signif-
icantly different (paired t-test, p < 0.001) so analyzing the
average of the effective doses versus the difference of the
effective doses was performed.
Figure 3 shows the Bland-Altman plot for the two meth-
ods of calculating the effective dose from a chest abdomen
pelvis scan. The height weight predictive model has a posi-
tive bias compared to the DLP CC method (mean of the
differences = 6.38 mSv). The positive bias indicates that
the height weight predictive model consistently estimated
slightly higher effective doses than the DLP CC method.
There is no significant systematic difference because the
line of equality is within the ±1.96 standard deviation
lines. All plotted values are within two standard deviations
(solid heavy horizontal lines) of the mean (dashed horizon-
tal line). Those plotted values that are near the -1.96 stan-
dard deviation line are a result of very large DLP values
due to the patient BMI being greater than the BMIs used
to develop the predictive model (Figure 4).
Discussion
In cardiology scans, it is well known that a patient’s BMI is
correlated with the effective dose from computed tomo-
graphy scans [26,27]. Since BMI is a quantity comprising
height and weight, the development of a model based
upon height and weight will allow for estimating effective
dose with minimal information and will result in similar
accuracy of effective dose estimates when compared to
current methods using CT machine-based parameters and
these parameters are unknown. There is currently no
known research specifically addressing such a model for
chest abdomen pelvis CT scans. This research was
designed to address that information gap.
The goal of using height and weight as predictors was to
obtain a minimally confounded estimate of the effect of
patient dimensions on effective dose from CT trauma pro-
tocols. A physician can utilize the predictive model (equa-
tion 5) to estimate the effective dose for the CT whole
body (chest abdomen pelvis) scan. Specific machine char-
acteristics were not assessed as predictors because this
information is often not known for retrospective
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Organ Female Male
Measured Absorbed Dose
(mGy)
Calculated Absorbed Dose
(mGy)
ABS %
Difference
Measured Absorbed Dose
(mGy)
Calculated Absorbed Dose
(mGy)
ABS %
Difference
Adrenals/Gall
Bladder
26.90 ± 0.03 25 ± 1 2 27.9 ± 0.4 23 ± 1 5
Brain 0.29 ± 0.02 0.4 ± 0.1 8 0.7 ± 0.3 0.4 ± 0.1 14
Colon 22.3 ± 0.7 21.1 ± 0.8 1 28 ± 5 20 ± 0.8 8
Esophagus 25 ± 1 23 ± 1 2 22.1 ± 0.4 21 ± 1 1
Eye 0.495 ± 0.008 NA 0.74 ± 0.08 NA
Kidney 24.2 ± 0.5 31.5 ± 0.9 7 24.2 ± 0.8 30.3 ± 0.9 5
Liver 26.0 ± 0.2 29.5 ± 0.3 3 26.3 ± 0.9 28.1 ± 0.3 2
Lung 27 ± 1 33.9 ± 0.7 6 24 ± 1 32.4 ± 0.6 7
Pancreas 25.9 ± 0.4 25.1 ± 0.7 1 28.5 ± 0.2 23.2 ± 0.7 5
Thymus 23.5 ± 0.3 25 ± 5 2 27.0 ± 0.5 24 ± 5 3
Thyroid 12.3 ± 0.4 24 ± 9 16 30.2 ± 0.8 24 ± 9 6
Uterus/Testes 25.6 ± 0.1 21 ± 4 5 8 ± 4 0.8 ± 0.4 41
Organ absorbed doses for a chest abdomen pelvis scan. The measured absorbed dose values are from the anthropomorphic phantoms and the calculated absorbed dose values are from the mathematical phantom.
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9Table 2 Estimates of the effective dose
Organ ICRP103 Tissue
Weighting Factor
Measured Equivalent Dose
(Female) (mSv)
Calculated Equivalent
Dose (mSv)
ABS Diff
(%)
Measured Equivalent Dose
(Male) (mSv)
Calculated Equivalent
Dose (mSv)
ABS Diff
(%)
Brain 0.01 0.0029 ± 0.0002 0.004 ± 0.001 0.007 ± 0.003 0.004 ± 0.001
Colon 0.12 2.68 ± 0.08 2.5 ± 0.1 3.4 ± 0.6 2.4 ± 0.1
Esophagus 0.04 1.00 ± 0.04 0.92 ± 0.04 0.88 ± 0.02 0.84 ± 0.04
Liver 0.04 1.040 ± 0.008 1.18 ± 0.01 1.05 ± 0.04 1.12 ± 0.01
Lung 0.12 3.24 ± 0.12 4.07 ± 0.08 2.9 ± 0.1 3.89 ± 0.07
Thymus 0.04 0.94 ± 0.01 1.0 ± 0.2 1.08 ± 0.02 1.0 ± 0.2
Thyroid 0.04 0.49 ± 0.02 1.0 ± 0.4 1.21 ± 0.03 1.0 ± 0.4
Remainder 0.12 3.08 ± 0.08 3.1 ± 0.5 2.7 ± 0.5 2.3 ± 0.2
Organs:
Pancreas
Uterus
Kidney
Adrenals/
Gall
Bladder
Effective Dose (mSv) 12.5 ± 0.2 13.7 ± 0.7 9% 13.1 ± 0.8 12.5 ± 0.6 5%
Effective dose for a chest abdomen pelvis scan.
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9assessment of effective dose from CT scans. The coeffi-
cient of determination, R
2, was used to describe the varia-
bility in the calculated effective dose explained by the
linear regression model.
Utilizing Bland-Altman [25,28] plots to compare two
methods allow us to determine whether or not the two
methods can be used interchangeably. Since both calcula-
tions are an estimate of the effective dose the limits of
agreement were set to be +/- 2 standard deviations of
mean difference of the two methods. Convention allows
that when the difference between the two methods lies
within two standard deviations of the difference mean,
either method can be used with respect to accuracy [29].
The height weight predictive model is consistent with
current literature which suggests that the DLP CC is
known to underestimate the effective dose per scan
[11,30-32]. Furthermore, literature suggests that experi-
mental measurements of effective dose will often be
higher than DLP CC methods for calculating effective
dose because DLP CC methods can underestimate the
effective dose by up to 37% [31-33]. Part of the reason for
this difference is that conversion factors are highly
dependent upon the specific size of the phantom used
and the assumed scanning length [30].
DLPs can also underestimate the total energy imparted
over the scanning length [11]. When scanning lengths
are increased or decreased, organs are either brought
into the scanning field-of-view or removed from the
scanning field-of-view. For scanning regions which
include fewer major organs (brain scan and cervical spine
scan), differences between various methods of calculating
effective doses result from dimensional differences
between phantoms and patients. Dose variations between
phantoms, physical and mathematical, will be less when
organs are small in volume and can be easily represented
by an averaged point dose estimate. Dose variations
between phantoms will also be less for large organs
which receive a fairly uniform absorbed dose throughout
its volume [34].
This research was limited in the verification and vali-
dation of the model by using only two reference anthro-
p o m o r p h i cp h a n t o m sa n do n et y p eo fC Ts c a n n e r .
Additional research should be performed verifying the
model with other CT scanner types since dose variations
Figure 2 E f f e c t i v eD o s eC o m p a r i s o n . Effective dose box-and-
whisker plot comparison showing the two different methods of
calculation.
Figure 3 Bland-Altman Analysis. Bland-Altman analysis of the two effective dose calculation methods (predictive model and the DLP CC
method). Y-axis difference values are calculated by subtracting the DLP CC values from the Predictive Model values.
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known to occur [35,36].
Conclusions
The model described in this article can be used to estimate
the effective dose from a chest abdomen pelvis CT scan to
a mathematical phantom based on a patient’sh e i g h ta n d
weight. Effective dose estimation gives the medical profes-
sional a means of comparing patient doses from CT with
those of other radiation diagnostic modalities. This model
allows for retrospective effective dose estimation when the
machine parameters are not known for patient popula-
tions of similar characteristics with the mathematical and
anthropomorphic phantoms.
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